Strength: 10 mg
Form: Tablets
Istalab D Tablet is a potent combination medication that includes Sitagliptin Phosphate I.P. at a dosage of 100 mg and Dapagliflozin Propanediol U.S.P. at 10 mg. This innovative formulation is specifically designed for the management of type 2 diabetes mellitus in adults. Sitagliptin, a DPP-4 inhibitor, enhances the body s ability to regulate blood sugar levels by increasing insulin secretion in response to meals and decreasing glucagon levels, which helps to lower glucose production in the liver. Dapagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, works by preventing the reabsorption of glucose in the kidneys, leading to increased glucose excretion through urine. This dual mechanism of action not only helps in achieving better glycemic control but also offers additional benefits such as weight loss and a reduction in blood pressure.
The combination of Sitagliptin and Dapagliflozin in Istalab D Tablet provides a comprehensive approach to diabetes management, making it particularly suitable for patients who require more than one medication to control their blood sugar levels effectively. This combination therapy is beneficial for individuals who may have not achieved adequate glycemic control with monotherapy or those who are starting treatment for the first time. By addressing multiple pathways involved in glucose metabolism, Istalab D Tablet helps patients maintain stable blood sugar levels, which is crucial for preventing the long-term complications associated with diabetes.
Panchkula
GSTTrustSEAL7 yrs
Call Now
+917942721111WhatsApp86% Response Rate
